|
 PH&T is an Italian pharmaceutical company engaged in research, development and production of generic drugs for specialist therapies and innovative medical devices, sold worldwide through licensees and distributors.
The company was founded in Milan in 1991 with the aim of selecting and developing niche products and selling them through firm commercial partnerships. In 2011 we are celebrating 20 years of activity.
PH&T specializes in difficult to formulate prescription products and has a consolidated experience in oral slow release, eye drop, nasal spray and injectable forms. Our offer allows generic companies to complement their product portfolio with difficult-to-formulate, not top-selling pharmaceuticals.
|
|
 PH&T and and Sterimax are proud to announce the successful registration of Calcitriol injection in Canada
Calcitriol Injection is indicated in the management of hypocalcemia in patients undergoing chronic renal dialysis.
|
|
Read more...
|
Zoledronic acid PH&T receives Marketing Authorisation in BE, EL, ES and IT with DE as RMS in the Decentralised Procedure.
August 2012 This decentralised approval concerns the generic version of zoledronic acid 4 mg / 5 mL concentrate for solution for infusion. PH&T is the only Company that has received MA for Zoledronic acid in COP plastic vial and glass vial.
|
|
Read more...
|
|
TURBOSPIN Dry Powder Inhaler has been registered in China
PH&T and Healthy Vision are proud to announce that TURBOSPIN Dry Powder Inhaler has gained approval by SFDA as a Medical Device in China. Turbospin registration will strengthen Health Vision’s respiratory franchise in the near future, especially in the COPD market.
|
|
Read more...
|
Forest Laboratories Receives European Marketing Approval for Colobreathe® (colistimethate sodium) with Turbospin® Dry Powder Inhaler.
|
|
Read more...
|
|
|
